Trofinetide    (DrugBank: Trofinetide)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
156レット症候群2

156. レット症候群 [臨床試験数:36,薬物数:49(DrugBank:19),標的遺伝子数:77,標的パスウェイ数:112
Searched query = "Rett syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 36 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04279314January 29, 202019/2/2020Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett SyndromeA 40-Week, Open-label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett SyndromeRett SyndromeDrug: TrofinetideACADIA Pharmaceuticals Inc.NULLEnrolling by invitation5 Years21 YearsFemale180Phase 3United States
2NCT04181723November 6, 201926/11/2019Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™)A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Trofinetide for the Treatment of Girls and Women With Rett SyndromeRett SyndromeDrug: Trofinetide;Other: PlaceboACADIA Pharmaceuticals Inc.NULLRecruiting5 Years20 YearsFemale184Phase 3United States